Clinical Trials Browser

Phase 4 × Has results × olaparib × Clear all

NCT05457257 2026-04-21

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

Phase 4 Active not recruiting

43 enrolled 16 charts

Metastatic Castration-resistant Prostate Cancer

NCT04330040 2025-03-10

SOLI

Phase 4 Completed

202 enrolled 15 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT02476968 2022-09-10

ORZORA

Phase 4 Completed

181 enrolled 24 charts

BRCA or HRR+ Mutated Ovarian Cancer Patients